UNASSIGNED: The records of adult patients who received intravenous therapy with 727 MCs and 293 LPCs from January 2021 to December 2023 at the University Clinical Centre of the Medical University of Warsaw were analysed.
UNASSIGNED: The main indication for cannulation was expected intravenous therapy over 5 days (81.66%, n = 833), of which 71.37% (n = 728) of patients in this group had concomitant difficult intravenous access (DIVA). Over 6 years, centrally inserted central catheters (CICCs) inserted due to DIVA were reduced from n = 108 in 2017 to n = 18 in 2023. The end of intravenous therapy was the reason for the removal of 64.6% of catheters (n = 659), including death and switch to CICCs as well. Complications leading to premature removal accounted for 31.2%, such as: occlusion (14.6%), patient self-removal (7.1%) and thrombosis (3.43%).
UNASSIGNED: The introduction of MCs as a possible option for peripheral venous access reduces the use of CVCs. Developing MCs programmes should be based on investing in staff competencies, which increases success rates. The nurses and physicians should be trained in infusion care to achieve better results in the use of MCs and LPCs. Increasing the competence of nurses in Poland is necessary for the implementation of full-service and top-level functioning of VAT.
分析了2021年1月至2023年12月在华沙医科大学临床中心接受727MC和293LPC静脉治疗的成年患者的记录。
■插管的主要适应症是5天内的预期静脉治疗(81.66%,n=833),其中该组71.37%(n=728)的患者伴有静脉通路困难(DIVA).超过6年,由于DIVA而插入的中央导管(CICC)从2017年的n=108减少到2023年的n=18.静脉治疗结束是64.6%的导管被移除的原因(n=659),包括死亡和转换到CICC。导致过早切除的并发症占31.2%,如:遮挡(14.6%),患者自我清除(7.1%)和血栓形成(3.43%)。
■引入MC作为外周静脉通路的可能选择,减少了CVC的使用。制定MC计划应基于对员工能力的投资,这提高了成功率。护士和医生应接受输液护理培训,以在使用MC和LPC方面取得更好的效果。提高波兰护士的能力对于实施增值税的全方位服务和顶级功能是必要的。